医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
异丁芬酸 | ibufenac | 1553-60-2 | C12H16O2 |
|
异丁基丙二酸二乙酯 | (2-methylpropyl)-propanedioic acid, diethyl ester | 10203-58-4 | C11H20O4 |
|
廿六烷二酸 | Tetrakosan-1,24-dicarbonsaeure | 3365-67-1 | C26H50O4 |
|
度鲁特韦中间体-6 | methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate | 1206102-07-9 | C17H19NO6 |
|
庚酸雌二醇 | 17β-estradiol enanthate | 4956-37-0 | C25H36O3 |
|
庚二酸二(N-琥珀酰亚胺基)酯 | pimelic acid dihydroxysuccinimide ester | 74648-14-9 | C15H18N2O8 |
|
并四噻吩 | thieno<2'',3'':4',5'>thieno<2',3'-d>thieno<3,2-b>thiophene | 124796-78-7 | C10H4S4 |
|
帕拉米松乙酸酯 | paramethasone acetate | 1597-82-6 | C24H31FO6 |
|
帕尼培南侧链 | (S)-3-mercapto-1-<N-(p-nitrobenzyloxycarbonyl)acetimidoyl>pyrrolidine | 90505-36-5 | C14H17N3O4S |
|
帕利哌酮十四酸酯 | paliperidone myristate | 1172995-11-7 | C37H53FN4O4 |
|
布酰胺 | Butoctamide | 32838-26-9 | C12H25NO2 |
|
巴豆醯胺 | crotonamide | 23350-58-5 | C4H7NO |
|
巴西芬净 | Basifungin | 127785-64-2 | C60H92N8O11 |
|
巴瑞克替尼中间体3 | (4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | 1187595-90-9 | C22H27N7O4S |
|
己二酸酐 | adipic anhydride | 2035-75-8 | C6H8O3 |
|
己二酸单叔丁酯 | 6-(tert-butoxy)-6-oxohexanoic acid | 52221-07-5 | C10H18O4 |
|
己二酸 1,6-二(2,5-二氧代-1-吡咯烷基)酯 | bis(2,5-dioxopyrrolidin-1-yl) adipate | 59156-70-6 | C14H16N2O8 |
|
巯基尼古胺 | thionicotinamide | 4621-66-3 | C6H6N2S |
|
巯基乙酸丁酯 | butyl thioglycolate | 10047-28-6 | C6H12O2S |
|
左羟丙哌嗪 | dextrodropropizine | 99291-24-4 | C13H20N2O2 |
|
左羟丙哌嗪 | levodropropizine | 99291-25-5 | C13H20N2O2 |
|
左美洛昔芬 | ormeloxifene | 78994-23-7 | C30H35NO3 |
|
左旋-3-溴樟脑 | endo-2-bromocamphor | 76-29-9 | C10H15BrO |
|
左乙拉西坦酸 | (R)-2-pyrrolidone-N-butyric acid | 103833-72-3 | C8H13NO3 |
|
山柰酚-3-O-(2,6-二-O-反式-对香豆酰基)-beta-D-吡喃葡萄糖苷 | kaempferol 3-O-[2'',6''-di-O-(trans-p-coumaroyl)]-β-D-glucopyranoside | 121651-61-4 | C39H32O15 |
|
山柰酚 3-O-(6-O-没食子酰)-beta-D-吡喃葡萄糖苷 | 6''-O-(3,4,5-trihydroxybenzoyl) 3-O-β-D-glucopyranosyloxy-4',5,7-trihydroxyflavone | 56317-05-6 | C28H24O15 |
|
尿苷-5'-三磷酸 | UTP | 63-39-8 | C9H15N2O15P3 |
|
尿嘧啶-D4 | 1,3,5,6-tetradeuterio-1<i>H</i>-pyrimidine-2,4-dione | 24897-55-0 | C4H4N2O2 |
|
尿嘧啶-D2 | 1,3-dideuterio-1<i>H</i>-pyrimidine-2,4-dione | 20666-60-8 | C4H4N2O2 |
|
尿嘧啶-D1 | <6-(2)H>-uracil | 24897-51-6 | C4H4N2O2 |
|
尿嘧啶-6-甲醛单水合物 | orotoaldehyde | 36327-91-0 | C5H4N2O3 |
|
尿嘧啶-4-乙酸 | 6-carboxymethyluracil | 4628-39-1 | C6H6N2O4 |
|
尿嘧啶-15N2 | [1,3-(15)N2]uracil | 5522-55-4 | C4H4N2O2 |
|
尿嘧啶 | uracil | 66-22-8 | C4H4N2O2 |
|
尼非卡兰中间体B4(1,3-二甲基-6-[2-(对甲基苯磺酰氧基)乙基胺]-2,4(1H.3H)-嘧啶双酮 | 1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino)-2,4(1H,3H)-pyrimidinedione | 130634-04-7 | C15H19N3O5S |
|
尼罗替尼单盐酸盐单水合物 | 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide monohydrochloride monohydrate | 923288-90-8 | C28H22F3N7O*ClH*H2O |
|
尼亚酰铵 | nialamide | 51-12-7 | C16H18N4O2 |
|
对苯二甲酰二苯胺 | N,N'-diphenylterephthalamide | 7154-31-6 | C20H16N2O2 |
|
对苯丁氧基苯甲酸 | 4-(4-phenylbutoxy)benzoic acid | 30131-16-9 | C17H18O3 |
|
对羟基苯海因 | 5-(4-hydroxy-phenyl)-imidazolidine-2,4-dione | 2420-17-9 | C9H8N2O3 |
|
对羟基二苯胺 | 4-anilinophenol | 122-37-2 | C12H11NO |
|
对硝基间苯二胺 | 2,4-diaminonitrobenzene | 5131-58-8 | C6H7N3O2 |
|
对硝基乙酰苯胺 | N-(4-Nitrophenyl)acetamide | 104-04-1 | C8H8N2O3 |
|
对甲苯磺酰脲 | 4-toluenesulfonylurea | 1694-06-0 | C8H10N2O3S |
|
对甲氧基肉桂酸甲酯 | 3-methoxybenzyl acrylate | 144261-46-1 | C11H12O3 |
|
对甲基间羟基二苯胺 | 3-(p-tolylamino)phenol | 61537-49-3 | C13H13NO |
|
对特丁基苯肼盐酸盐 | p-tert-butylphenylhydrazine | 61765-93-3 | C10H16N2 |
|
对氯三氟甲氧基苯 | 1-chloro-4-(trifluoromethoxy)benzene | 461-81-4 | C7H4ClF3O |
|
对新戊酰氧基苯磺酰氯 | 4-pivaloyloxybenzenesulfonyl chloride | 150374-99-5 | C11H13ClO4S |
|
对丁氨基苯甲酸乙酯 | ethyl 4-(butylamino)benzoate | 94-32-6 | C13H19NO2 |
|